Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Regulation

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

The Opportunities and Challenges Posed by Biosimilar Interchangeability

Interchangeable Biosimilars

The Opportunities and Challenges Posed by Biosimilar Interchangeability

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-23-NI-01March 07, 2023

Cosmeceuticals Are Here. When Will Regulations Catch Up?

Cosmeceuticals

Cosmeceuticals Are Here. When Will Regulations Catch Up?

Ameena Pathan

That's Nice LLC

PAO-08-022-CL-09August 31, 2022

Duplicated Document and Data Creation Must Stop!

Electronic Documentation

Duplicated Document and Data Creation Must Stop!

Remco Munnik

PAO-08-022-CL-02August 02, 2022

Vote Expected on Democratic Drug Pricing Bill

Drug Pricing

Vote Expected on Democratic Drug Pricing Bill

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M12-19-NI-009December 13, 2019

China to Introduce Regulations on Gene Editing

Gene Editing

China to Introduce Regulations on Gene Editing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M05-19-NI-031May 29, 2019